Overall Fundamental outlook

Business Operations:

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women's health, metabolic, central nervous system, vaccines, and multispecialty, including insomnia, vitamin D deficiency, pre-term labor, and pain management. It provides anti-infective, cardio-diabeto, hepatology, hormones, neuro-psychiat, hepatic, gennext, and consumer care products. The company was founded in 1910 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.

Revenue projections:

Revenue projections for ABBOTINDIA
Revenue projections for ABBOTINDIA

ABBOTINDIA's revenue projections show a decrease from last year, which tends to make investors more cautious. This could have a negative impact on the company's bottom line, as lower revenues typically suggest reduced profitability and growth potential, prompting concern among investors.

Financial Ratios:

currentRatio 3.38600
forwardPE 37.20861
debtToEquity 4.64600
earningsGrowth 0.27900
revenueGrowth 0.11500
grossMargins 0.42622
operatingMargins 0.25590
trailingEps 666.29000
forwardEps 0.00000

ABBOTINDIA's current ratio being 3.386 shows it has more than enough assets to cover its short-term debts. The company's liquidity position is strong, with ample cash reserves available to meet its immediate financial obligations without strain.
ABBOTINDIA's positive earnings and revenue growth signal the company's business is on track for further expansion. These strong financial trends suggest that ABBOTINDIA will continue to grow its operations, driven by increasing profits and revenue.
Abbott India Limited's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness.

Price projections:

Price projections for ABBOTINDIA
Price projections for ABBOTINDIA

ABBOTINDIA's price projections have gradually increased over time, indicating that analysts are becoming more optimistic about the company's prospects. This suggests confidence in ABBOTINDIA's ability to achieve future growth.

Recommendation changes over time:

Recommendations trend for ABBOTINDIA
Recommendations trend for ABBOTINDIA


Analysts' buy bias for ABBOTINDIA signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to ABBOTINDIA, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.